Significant treatment attrition rate seen in multiple myeloma

by Elana GotkineThere is a significant treatment attrition rate in newly diagnosed multiple myeloma (NDMM), according to a study published in the November issue ofLeukemia & Lymphoma.Victor

Updated on: December 21,2023

Significant treatment attrition rate seen in multiple myeloma

by Elana GotkineThere is a significant treatment attrition rate in newly diagnosed multiple myeloma (NDMM), according to a study published in the November issue ofLeukemia & Lymphoma.Victor

Updated on:December 21,2023

Diets rich in refined fiber may increase liver cancer risk in some individuals

by Tyrel Linkhorn,University of ToledoGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.033Many people commonly consume fiber-enriched foods to p

Updated on: December 20,2023

Diets rich in refined fiber may increase liver cancer risk in some individuals

by Tyrel Linkhorn,University of ToledoGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.033Many people commonly consume fiber-enriched foods to p

Updated on:December 20,2023

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on: December 17,2023

RET inhibitor selpercatinib demonstrates durable responses in tumor-agnostic population

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses ac

Updated on:December 17,2023

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on: December 20,2023

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on:December 20,2023

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America

Updated on: December 19,2023

Overall cancer mortality continued to decline from 2019 to 2020

by Elana GotkineOverall cancer mortality is continuing to decline, according to a study published online Jan. 12 inCA: A Cancer Journal for Clinicians.Rebecca L. Siegel, M.P.H., from the America

Updated on:December 19,2023

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Updated on: December 22,2023

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Updated on:December 22,2023

A Surprising Revelation: Cancer Cells' Ability to Build "Electrical Grids" for Tumor Spread

Updated on: March 01,2025

A Surprising Revelation: Cancer Cells' Ability to Build "Electrical Grids" for Tumor Spread

Updated on:March 01,2025

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer

Updated on: December 20,2023

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer

Updated on:December 20,2023

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on: January 04,2024

Making glioblastoma more vulnerable to treatment

byMedical College of Georgia at Augusta UniversityDr. Waaqo Daddacha. Credit: Michael Holahan, Augusta UniversityIn the tough war against glioblastoma, scientists are taking a cue from viruses o

Updated on:January 04,2024

Two common types of antidepressants found to be safe for most stroke survivors

by American Heart AssociationCredit: Unsplash/CC0 Public DomainMost stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented

Updated on: May 06,2024

Two common types of antidepressants found to be safe for most stroke survivors

by American Heart AssociationCredit: Unsplash/CC0 Public DomainMost stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented

Updated on:May 06,2024

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on: December 22,2023

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on:December 22,2023

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on: December 20,2023

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on:December 20,2023